Fennell T R, Miller J A, Miller E C
Cancer Res. 1984 Aug;44(8):3231-40.
The hepatocarcinogen safrole is metabolized both to 1'-hydroxysafrole, a proximate hepatocarcinogen, and to 1'-oxosafrole, which is electrophilic but has little or no carcinogenic activity in rats and mice. As a part of a study on the metabolic interrelationships of these metabolites, their biliary and urinary conjugates were investigated. Administration of a single i.p. dose of [2',3'-3H]-1'-oxosafrole to male Sprague-Dawley rats or female CD-1 mice with cannulated bile ducts resulted in the excretion of 2 major biliary metabolites. These metabolites were isolated by high-performance liquid chromatography and characterized by 1H-nuclear magnetic resonance spectroscopy as 3'-(glutathion-S-yl)-1'-oxo-2',3'-dihydrosafrole and 3'-(N-acetylcystein-S-yl)-1'-oxo-2',3'-dihydrosafrole. The latter conjugate was also found in the urine. These conjugates were synthesized by non-enzymatic reaction of 1'-oxosafrole with glutathione and N-acetylcysteine at pH 8. After a single i.p. dose of [2',3'-3H]-1'-hydroxysafrole, the major biliary and urinary metabolite in rats was the glucuronide of this alcohol. Lower levels of the glutathione and N-acetylcysteine conjugates of 1'-oxosafrole appeared in the bile, and the latter conjugate was also found in the urine. Similar findings were made on the biliary metabolites of 1'-hydroxysafrole in mice. Although the sulfuric acid ester of 1'-hydroxysafrole is the major metabolite leading to the formation of DNA adducts in the liver, it was, at most, of minor importance in the formation of glutathione adducts. Only a very small percentage of a dose of 1'-hydroxysafrole was excreted in the bile of rats or mice as products that cochromatographed with 1'-(glutathion-S-yl)-safrole and 3'-(glutathion-S-yl)-isosafrole; no 3'-(N-acetylcystein-S-yl)-isosafrole was detected. These latter conjugates were synthesized by nonenzymatic reactions at pH 8.5 of the model electrophilic ester 1'-acetoxysafrole with glutathione or N-acetylcysteine.
肝癌致癌物黄樟素可代谢生成1'-羟基黄樟素(一种直接致癌物)和1'-氧代黄樟素,后者具有亲电性,但在大鼠和小鼠中几乎没有致癌活性。作为对这些代谢物代谢相互关系研究的一部分,对它们的胆汁和尿液结合物进行了研究。给雄性Sprague-Dawley大鼠或雌性CD-1小鼠(已插入胆管)腹腔注射单剂量的[2',3'-3H]-1'-氧代黄樟素后,产生了2种主要的胆汁代谢物。这些代谢物通过高效液相色谱法分离,并通过1H-核磁共振光谱鉴定为3'-(谷胱甘肽-S-基)-1'-氧代-2',3'-二氢黄樟素和3'-(N-乙酰半胱氨酸-S-基)-1'-氧代-2',3'-二氢黄樟素。后一种结合物在尿液中也有发现。这些结合物是通过1'-氧代黄樟素与谷胱甘肽和N-乙酰半胱氨酸在pH 8下的非酶反应合成的。给大鼠腹腔注射单剂量的[2',3'-3H]-1'-羟基黄樟素后,大鼠胆汁和尿液中的主要代谢物是该醇的葡糖醛酸苷。1'-氧代黄樟素的谷胱甘肽和N-乙酰半胱氨酸结合物在胆汁中的含量较低,后一种结合物在尿液中也有发现。在小鼠中对1'-羟基黄樟素的胆汁代谢物也有类似的发现。尽管1'-羟基黄樟素的硫酸酯是导致肝脏中DNA加合物形成的主要代谢物,但它在谷胱甘肽加合物的形成中至多只起次要作用。在大鼠或小鼠的胆汁中,只有极少量剂量的1'-羟基黄樟素以与1'-(谷胱甘肽-S-基)-黄樟素和3'-(谷胱甘肽-S-基)-异黄樟素共色谱的产物形式排出;未检测到3'-(N-乙酰半胱氨酸-S-基)-异黄樟素。后一种结合物是通过模型亲电酯1'-乙酰氧基黄樟素与谷胱甘肽或N-乙酰半胱氨酸在pH 8.5下的非酶反应合成的。